s&o logo
  • News
  • Trade Ideas
  • Education
  • Community
Sign Up!
News

Ideal Power just announced a global distribution partnership with RYOSHO

August 8, 2024 George Levine No comments yet

Ideal Power Inc. (Nasdaq: IPWR), an innovator in semiconductor power switch technology, has announced a strategic agreement with RYOSHO U.S.A., Inc., a subsidiary of RYODEN CORPORATION, for the global distribution of its B-TRAN technology. RYOSHO has placed initial orders from a large global customer interested in utilizing Ideal Power’s products for solid-state circuit protection applications.

This partnership marks a significant step in Ideal Power’s commercialization strategy by expanding its distribution network with a second major distributor. RYOSHO, known for its technical sales expertise and strong market presence, especially in Asia, is expected to enhance the reach of Ideal Power’s B-TRAN technology. Ideal Power’s CEO, Dan Brdar, highlighted the importance of this collaboration, noting that RYOSHO’s expertise in securing sales for new technologies will help secure additional orders and potentially lead to design wins and custom development agreements.

Ideal Power’s asset-light business model focuses on leveraging existing silicon processing and distribution infrastructure, allowing the company to concentrate on advancing its B-TRAN technology without significant capital investment. This strategy aligns with the growing demand for efficient semiconductor solutions across various industries.

The B-TRAN bidirectional semiconductor power switch offers significant advantages over traditional power switches, including higher efficiency and cost-effectiveness. It is designed for applications requiring solid-state circuit protection and aligns with global trends toward more sustainable energy solutions.

Through this partnership, Ideal Power aims to capitalize on the expanding global market for advanced semiconductor power solutions. By collaborating with RYOSHO, Ideal Power is well-positioned to accelerate the adoption of B-TRAN technology and expand its market presence across key industries, including automotive, energy, and industrial applications.

In summary, the partnership with RYOSHO strengthens Ideal Power’s global distribution capabilities and underscores its commitment to commercializing its innovative B-TRAN technology. This collaboration is expected to drive growth and innovation, positioning Ideal Power as a leader in the semiconductor industry’s transition toward more efficient and sustainable power solutions.

  • Stocks

Post navigation

Previous
Next

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Education (15)
  • Featured (46)
  • News (85)
  • Trade Ideas (39)

Recent posts

  • FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
  • Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine
  • flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

Tags

BDRX CDT Conduit Conference Call CURR CURRENC Earnings Evergreen GH Research GHRS Grail GRAL HOLO IINN Inspira Technologies Interview IPWR JTAI KULR LCID Litigation LLY Lucid Motors M&A MedTech MicroCloud Movers MSTR My Size MYSZ News NLSP Novo Nordisk NVO Options Partnerships QNTM Quantum BioPharma Stock Market Stocks TAOP TELO Telomir Pharmaceuticals Traws Pharma TRWS

Continue reading

Featured, News, Trade Ideas

FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity

March 3, 2025 Elisa Clay No comments yet

BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single site involved in the TRANQUILITY II Phase 3 trial under 21 C.F.R.20.64(d)(3). The FDA’s designation of “Voluntary Action Indicated” (VAI) signals that while minor issues may have been identified, no regulatory action is required, further […]

Featured, News, Trade Ideas

Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine

February 20, 2025 Elisa Clay No comments yet

Telomir Pharmaceuticals (NASDAQ: TELO) has achieved a major scientific breakthrough by stabilizing Silver(II) (Ag²⁺) using its proprietary compound, Telomir-1. This advancement overcomes a key challenge in silver-based medicine, unlocking new possibilities for antimicrobial treatments, wound care, and infection-resistant medical coatings. Silver(II) offers superior antibacterial action, faster wound healing, and immune-modulating properties compared to traditional Silver(I) […]

Featured, News, Trade Ideas

flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

February 14, 2025 Elisa Clay No comments yet

flyExclusive (NYSE American: FLYX), a leading provider of premium jet charter experiences, has entered into a definitive agreement to acquire the aviation business of Jet.AI (NASDAQ: JTAI). The deal will allow flyExclusive to expand its fleet and market presence while enabling Jet.AI to transition into a pure-play AI solutions company. Under the terms of the […]

s&o logo

Our primary goal is to empower retail investors with helpful news, guides and trading ideas.

Helpful Links
  • News
  • Trade Ideas
  • Education
  • Community
Resources
  • Privacy Policy
  • Terms & Conditions
  • Contact
Get in touch
  • Email us!

© Copyright 2024, stocks&options. All Rights Reserved.